[Business Wire] Cigna Corp (NYSE:CI)(TREND ANALYSIS) plans in Arizona have received top ratings for quality care and customer service. Most recently, Cigna (CI) was the only Medicare Advantage HMO health plan in Arizona to receive a 5 out of 5 star rating by the Centers for Medicare & Medicaid Services (CMS).
CMS’s Five-Star Quality Rating System rates Medicare Advantage plans on a scale of 1 to 5 stars, 5 being the highest, as a way to help consumers judge the quality and customer service of Medicare Advantage plan choices. Cigna’s Medicare Advantage plans in Arizona have achieved a 4.5 out of 5 star rating from CMS for the last four consecutive years. No other Medicare Advantage HMO plan in the state of Arizona has a higher rating than Cigna HealthCare of Arizona.
Stock Performance: Click here for a free comprehensive Trend Analysis Report
Cigna Corp (NYSE:CI) stock is currently trading 19.38% below its 52-week-high, 56.95% above its 52-week-low. The 1-year stock price history is in the range of $87.67 – $170.68. Cigna Corp (CI) has a price to earnings ratio of 17.05 versus Healthcare sector average of 43.93. CI stock price has outperformed the S&P 500 by 36.6%. The Medical HMO company is currently valued at $35.43 billion and its share price closed the last trading session at $137.6. The stock has a 50-day moving average of $138.71 and a 200-day moving average of $141.18.
Cigna Corp (CI) current short interest stands at 2.64 million shares. It has increased by 5% from the same period of last month. Around 2% of the company’s shares, which are float, are short sold. With a 10-days average volume of 1.72 million shares, the number of days required to cover the short positions stand at 1.6 days.
The company is expected to announce next quarter earnings on November 06, at consensus estimate of $2.17. Cigna Corp (CI) reported last quarter earnings on July 30. The Medical HMO company announced earnings per share of $2.55 against a consensus Street estimate of $2.38, beating the average estimate by $0.17. This corresponds to an increase of $0.42 compared to the same quarter of the previous fiscal year.
Is this a Buying Opportunity? Click here for a free Trend Analysis Report
There are currently seventeen analysts that cover Cigna Corp stock. Of those seventeen, ten have a Buy rating, seven have a Hold rating. On a consensus basis this yields to an Overweight rating. The consensus target price stands at $171.36.
A recent analyst activity consisted of Cowen & Company reiterating their Outperform stance on September 22. Cowen & Company increased their price target on CI from $145 to $160. This corresponds to a 16.28% upside from the last closing price. On the date of report, the stock closed at $141.15.
JP Morgan initiated their coverage on the stock with Overweight rating on September 16. On the date of report, the stock closed at $142.59.
Another research firm was Barclays who reiterated their Equal-weight stance on July 31. Barclays increased their price target on Cigna Corp from $137 to $156. This translates to a 13.37% upside from the last closing price. On the date of report, the stock closed at $144.06.
Cigna Corporation, through its subsidiaries, provides group life and health insurance, managed care products and services, retirement products and services, and individual financial services worldwide. The Company also sells individual life and health insurance and annuity products in selected international locations.